Contact hours available until 8/31/2020. Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. Nephrology Nursing Journal Editorial Board Statements of Disclosure: In accordance with ANCC governing rules Nephrology Nursing Journal Editorial Board statements of disclosure are published with each CNE offering. The statements of disclosure for this offering are published below.
Paula Dutka, MSN, RN, CNN, disclosed that she is a coordinator of Clinical Trials for the following sponsors: Amgen, Rockwell Medical, Keryx Biopharmaceuticals, Akebia Therapeutics, and Dynavax Technologies.
Norma J. Gomez, MBA, MSN, CNNe, disclosed that she is a member of the ZS Pharma Advisory Council.
Tamara M. Kear, PhD, RN, CNS, CNN, disclosed that she is a member of the ANNA Board of Directors, serves on the Scientific Advisory Board for Kibow Biotech, Inc., and is employed by Fresenius Kidney Care as an acute hemodialysis RN.
All other members of the Editorial Board had no actual or potential conflict of interest in relation to this continuing nursing education activity.
This article was reviewed and formatted for contact hour credit by Beth Ulrich, EdD, RN, FACHE, FAAN, Nephrology Nursing Journal Editor, and Sally Russell, MN, CMSRN, CPP, ANNA Education Director. Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
This CNE article meets the Nephrology Nursing Certification Commission’s (NNCC’s) continuing nursing education requirements for certification and recertification. Learning Outcome: After completing this learning activity, the learner will be able to discuss an intervention program to improve the resilience of patients on hemodialysis.
Symptoms, Coping, and Quality of Life of People with Chronic Kidney Disease
1.30 - CH
You must be logged in and own this product in order to post comments.
10/24/18 1:07 am
This study seems to be incomplete.
12/16/19 11:59 am
Great class, thank you
12/16/19 12:02 pm
12/16/19 5:36 pm
Good reminder for all nephrology nurses about how fragile our patients can be and the emotional support that is needed as well
12/17/19 1:39 am
The quality of life of the patient will also depend on the support system surrounding him/her.
12/21/19 4:29 am
The article itself was a well structured research article with good points. I think these problems have been fairly well defined. From my perspective I would like to see more research published about how well different interventions work to improve patient's quality of life (CBT, antidepressants, structured physical exercise) and how to encourage/convince patients to agree to those that have been shown to be beneficial. My biggest issue for the article the size of the font for the over 50 crowd. It was pretty small even with my readers. I've noticed this when I try to read the journal online I have problems as well so am less likely to attempt. If there was a way to increase the gain for the online articles it would be appreciated.
12/25/19 5:20 pm
I love this article. As care givers it's easy to be task oriented and not recognize the difficulty patients have coping with a chronic illness.
Anabelle Alarzar Tipan
12/27/19 8:30 pm
12/31/19 6:59 pm
Although still a good number I saw where there were only 42 participants. The article does recognize the small sample and this is where it starts .. Good job!! In my 23 years of dialysis I feel these numbers are accurate. Fatigue is the number one complaint I hear from my patients. Well done and thanks for the article Mary, Kara & Anita.